Julie Caramel
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Cell Biology top 5%
- Co-authors
- Alain PuisieuxThomas BrabletzStéphane DalleStéphane AnsieauFrédérique QuignonGeoffrey RichardOlivier DelattreJames H. Pringle
- Topics
- CAR-T cell therapy research (8 papers)Immunotherapy and Immune Responses (7 papers)Melanoma and MAPK Pathways (6 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Experimental Medicine
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Julie Caramel
29 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.4k
- Oncology 924
- Cancer Research 562
- Immunology 290
- Cell Biology 236
Countries citing papers authored by Julie Caramel
This map shows the geographic impact of Julie Caramel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Caramel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Caramel more than expected).
Fields of papers citing papers by Julie Caramel
This network shows the impact of papers produced by Julie Caramel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Caramel. The network helps show where Julie Caramel may publish in the future.
Co-authorship network of co-authors of Julie Caramel
This figure shows the co-authorship network connecting the top 25 collaborators of Julie Caramel. A scholar is included among the top collaborators of Julie Caramel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Caramel. Julie Caramel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 55 | |
| 8 | 13 | |
| 9 | 10 | |
| 10 | 14 | |
| 11 | 1 | |
| 12 | 18 | |
| 13 | 31 | |
| 14 | 8 | |
| 15 | 33 | |
| 16 | Oncogenic roles of EMT-inducing transcription factorsbreakdown → | 823 |
| 17 | 378 | |
| 18 | 42 | |
| 19 | 47 | |
| 20 | 166 |
About Julie Caramel
Julie Caramel is a scholar working on Oncology, Immunology and Immunology and Allergy, having authored 29 papers that have together received 2.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (7 papers) and Melanoma and MAPK Pathways (6 papers). The work is most often cited by research in Cancer Research (562 citations), Oncology (924 citations) and Molecular Biology (1.4k citations). Julie Caramel has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Alain Puisieux, Thomas Brabletz, Stéphane Dalle, Stéphane Ansieau, Frédérique Quignon, Geoffrey Richard, Olivier Delattre, James H. Pringle, Joël Lachuer and Joy Osborne. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.